Compare

Central Garden & Pet/$CENT

1D1W1M3M6MYTD1Y5YMAX

About Central Garden & Pet

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.
Ticker
$CENT
Primary listing
NASDAQ
Employees
5,850

CENT Metrics

BasicAdvanced
$2.5B
17.07
$2.67
0.59
-

What the Analysts think about CENT

Analyst ratings (Buy, Hold, Sell) for Central Garden & Pet stock.
Analyst projections of the future price of Central Garden & Pet stock.

Bulls say / Bears say

Organic sales rose 2% in Q3 and gross margin widened 130 basis points, while Central raised its FY26 non-GAAP EPS outlook to $2.85 or better from $2.70 or better. That points to improving profitability despite the exit from lower-margin distribution. (Central Garden & Pet Company)
Garden sales grew 3% to $482 million in Q3 and operating income rose 9%, led by wild bird feed, fertilizer, controls and grass seed. This segment is delivering growth as Central reshapes its portfolio. (Central Garden & Pet Company)
Central has added Burpee, a heritage seed and young-plant brand with established digital capabilities, and agreed to acquire an 80% stake in TRIXIE. The deals broaden its Garden offering and give it a platform to expand in Europe’s pet market. (Central Garden & Pet Company, Central Garden & Pet Company)
Q3 reported sales fell 8%, while non-GAAP diluted EPS slipped to $1.54 from $1.56. The sales fall mainly reflects the pet distribution exit, but reported growth and near-term earnings momentum remain subdued. (Central Garden & Pet Company)
The TRIXIE deal requires €340 million at closing, with up to €60 million more possible. Closing, integration and delivering the expected benefits create execution risk for a sizeable cross-border acquisition. (Central Garden & Pet Company)
Central’s FY26 outlook assumes a competitive, promotional retail market, value-focused consumers, existing tariffs and inflation in selected commodities. Persistent cost pressure or weak demand could make its raised earnings outlook harder to achieve. (Central Garden & Pet Company)
Data summarised monthly by Lightyear AI. Last updated on 20 Oct 2026.

CENT Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

CENT Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.